Related Experiment Video
Updated: Jul 18, 2026
23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries
1Mycobacteria Reference Center, Faculty of Medicine, University of Córdoba, Spain. mi1carom@uco.es
Microbial Drug Resistance (Larchmont, N.Y.)
|March 17, 2005
Summary
Intravenous drug use, nursing home residency, and previous tuberculosis are key risk factors for multidrug-resistant tuberculosis in Europe. Public health policies must address these to control resistant strains.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- Multidrug resistance (MDR) in tuberculosis (TB) poses a significant global health threat.
- Identifying risk factors is crucial for effective prevention and control strategies, particularly in the European Union.
Purpose of the Study:
- To identify and analyze statistically significant risk factors associated with multidrug resistance in pulmonary tuberculosis.
- To inform public health policy for monitoring and controlling MDR-TB within the European Union.
Main Methods:
- Prospective epidemiological case-control study conducted between 1997 and 2000 in France, Germany, Italy, and Spain.
- Involved 138 cases and 276 controls with clinically diagnosed and microbiologically confirmed pulmonary tuberculosis.
- Statistical analysis to determine odds ratios (OR) for identified risk factors.
Main Results:
- Significant risk factors for MDR-TB included intravenous drug use (OR 4.68), asylum-seeker support (OR 2.55), nursing home residency (OR 2.05), and previous TB (OR 2.03).
- Other factors identified were prison (OR 2.02), known TB contacts (OR 2.01), immunosuppression (OR 1.96), AIDS (OR 1.96), current pulmonary TB (OR 1.77), and healthcare worker status (OR 1.69).
- These factors were analyzed across the four European Union countries studied.
Conclusions:
- Specific risk factors for multidrug-resistant pulmonary tuberculosis have been identified in four EU countries.
- These findings necessitate tailored public health policies for monitoring and control of MDR-TB across the EU.
- Addressing these risk factors is critical for managing this serious, albeit rare, condition.
Related Concept Videos
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...